Kathleen Dunne Albright Los,Louie Daniel Garcia,Stephanie Kurz,Vladimir Kharitonov
申请号：
GB201621448
公开号：
GB2541835A
申请日:
2016.01.20
申请国别(地区):
GB
年份:
2017
代理人:
摘要：
Some embodiments of the present application are related to multivesicular liposome formulations comprising tranexamic acid (TXA) for the purpose of minimizing the side effects of unencapsulated tranexamic while maintaining or improving efficacy and lengthening the duration of the effect. Methods of making and administering the tranexamic acid encapsulated multivesicular liposome formulations and their use as medicaments are also provided.
